238 related articles for article (PubMed ID: 19997770)
1. Effects of deferasirox and deferiprone on cellular iron load in the human hepatoma cell line HepaRG.
Gaboriau F; Leray AM; Ropert M; Gouffier L; Cannie I; Troadec MB; Loréal O; Brissot P; Lescoat G
Biometals; 2010 Apr; 23(2):231-45. PubMed ID: 19997770
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative and apoptotic effects in rat and human hepatoma cell cultures of the orally active iron chelator ICL670 compared to CP20: a possible relationship with polyamine metabolism.
Lescoat G; Chantrel-Groussard K; Pasdeloup N; Nick H; Brissot P; Gaboriau F
Cell Prolif; 2007 Oct; 40(5):755-67. PubMed ID: 17877614
[TBL] [Abstract][Full Text] [Related]
3. Iron mobilization, cytoprotection, and inhibition of cell proliferation in normal and transformed rat hepatocyte cultures by the hydroxypyridinone CP411, compared to CP20: a biological and physicochemical study.
Gaboriau F; Chantrel-Groussard K; Rakba N; Loyer P; Pasdeloup N; Hider RC; Brissot P; Lescoat G
Biochem Pharmacol; 2004 Apr; 67(8):1479-87. PubMed ID: 15041465
[TBL] [Abstract][Full Text] [Related]
4. Ethanol effect on cell proliferation in the human hepatoma HepaRG cell line: relationship with iron metabolism.
Tuoi Do TH; Gaboriau F; Ropert M; Moirand R; Cannie I; Brissot P; Loréal O; Lescoat G
Alcohol Clin Exp Res; 2011 Mar; 35(3):408-19. PubMed ID: 21143242
[TBL] [Abstract][Full Text] [Related]
5. In vitro blood distribution and plasma protein binding of the iron chelator deferasirox (ICL670) and its iron complex Fe-[ICL670]2 for rat, marmoset, rabbit, mouse, dog, and human.
Weiss HM; Fresneau M; Camenisch GP; Kretz O; Gross G
Drug Metab Dispos; 2006 Jun; 34(6):971-5. PubMed ID: 16531476
[TBL] [Abstract][Full Text] [Related]
6. The effects of deferiprone and deferasirox on the structure and function of beta-thalassemia hemoglobin.
Moosavi-Movahedi AA; Mousavy SJ; Divsalar A; Babaahmadi A; Karimian K; Shafiee A; Kamarie M; Poursasan N; Farzami B; Riazi GH; Hakimelahi GH; Tsai FY; Ahmad F; Amani M; Saboury AA
J Biomol Struct Dyn; 2009 Dec; 27(3):319-39. PubMed ID: 19795915
[TBL] [Abstract][Full Text] [Related]
7. Synergistic intracellular iron chelation combinations: mechanisms and conditions for optimizing iron mobilization.
Vlachodimitropoulou Koumoutsea E; Garbowski M; Porter J
Br J Haematol; 2015 Sep; 170(6):874-83. PubMed ID: 26033030
[TBL] [Abstract][Full Text] [Related]
8. The iron chelator, deferasirox, as a novel strategy for cancer treatment: oral activity against human lung tumor xenografts and molecular mechanism of action.
Lui GY; Obeidy P; Ford SJ; Tselepis C; Sharp DM; Jansson PJ; Kalinowski DS; Kovacevic Z; Lovejoy DB; Richardson DR
Mol Pharmacol; 2013 Jan; 83(1):179-90. PubMed ID: 23074173
[TBL] [Abstract][Full Text] [Related]
9. Antiproliferative effect on HepaRG cell cultures of new calix[4]arenes.
Rouge P; Pires VS; Gaboriau F; Dassonville-Klimpt A; Guillon J; Nascimento SD; Leger JM; Lescoat G; Sonnet P
J Enzyme Inhib Med Chem; 2010 Apr; 25(2):216-27. PubMed ID: 19883235
[TBL] [Abstract][Full Text] [Related]
10. Multidentate pyridinones inhibit the metabolism of nontransferrin-bound iron by hepatocytes and hepatoma cells.
Chua AC; Ingram HA; Raymond KN; Baker E
Eur J Biochem; 2003 Apr; 270(8):1689-98. PubMed ID: 12694182
[TBL] [Abstract][Full Text] [Related]
11. In vitro antimalarial activity of ICL670: a further proof of the correlation between inhibition of β-hematin formation and of peroxidative degradation of hemin.
Sonnet P; Mullié C
Exp Parasitol; 2011 May; 128(1):26-31. PubMed ID: 21295029
[TBL] [Abstract][Full Text] [Related]
12. Chelation of cadmium by combining deferasirox and deferiprone in rats.
Jamilaldin Fatemi S; Saljooghi AS; Balooch FD; Iranmanesh M; Golbafan MR
Toxicol Ind Health; 2011 May; 27(4):371-7. PubMed ID: 21245204
[TBL] [Abstract][Full Text] [Related]
13. Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells.
Glickstein H; El RB; Shvartsman M; Cabantchik ZI
Blood; 2005 Nov; 106(9):3242-50. PubMed ID: 16020512
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative and iron chelating efficiency of the new bis-8-hydroxyquinoline benzylamine chelator S1 in hepatocyte cultures.
Lescoat G; Léonce S; Pierré A; Gouffier L; Gaboriau F
Chem Biol Interact; 2012 Jan; 195(2):165-72. PubMed ID: 22197641
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative effect of deferiprone on the Hep G2 cell line.
Chenoufi N; Drénou B; Loréal O; Pigeon C; Brissot P; Lescoat G
Biochem Pharmacol; 1998 Aug; 56(4):431-7. PubMed ID: 9763218
[TBL] [Abstract][Full Text] [Related]
16. Expanding the Therapeutic Potential of the Iron Chelator Deferasirox in the Development of Aqueous Stable Ti(IV) Anticancer Complexes.
Loza-Rosas SA; Vázquez-Salgado AM; Rivero KI; Negrón LJ; Delgado Y; Benjamín-Rivera JA; Vázquez-Maldonado AL; Parks TB; Munet-Colón C; Tinoco AD
Inorg Chem; 2017 Jul; 56(14):7788-7802. PubMed ID: 28644630
[TBL] [Abstract][Full Text] [Related]
17. Treating iron overload: the state of the art.
Hershko C
Semin Hematol; 2005 Apr; 42(2 Suppl 1):S2-4. PubMed ID: 15846582
[No Abstract] [Full Text] [Related]
18. Hepatocyte iron loading capacity is associated with differentiation and repression of motility in the HepaRG cell line.
Troadec MB; Glaise D; Lamirault G; Le Cunff M; Guérin E; Le Meur N; Détivaud L; Zindy P; Leroyer P; Guisle I; Duval H; Gripon P; Théret N; Boudjema K; Guguen-Guillouzo C; Brissot P; Léger JJ; Loréal O
Genomics; 2006 Jan; 87(1):93-103. PubMed ID: 16325370
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, metabolism, and disposition of deferasirox in beta-thalassemic patients with transfusion-dependent iron overload who are at pharmacokinetic steady state.
Waldmeier F; Bruin GJ; Glaenzel U; Hazell K; Sechaud R; Warrington S; Porter JB
Drug Metab Dispos; 2010 May; 38(5):808-16. PubMed ID: 20097723
[TBL] [Abstract][Full Text] [Related]
20. Fenton chemistry and iron chelation under physiologically relevant conditions: Electrochemistry and kinetics.
Merkofer M; Kissner R; Hider RC; Brunk UT; Koppenol WH
Chem Res Toxicol; 2006 Oct; 19(10):1263-9. PubMed ID: 17040095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
